The parents of a Washington State University freshman who died by suicide have filed a sweeping lawsuit against Hims & Hers Health Inc., alleging the telehealth giant rushed their son into a dangerous antidepressant regimen despite clear warnings about its risks to adolescents and his own history of self-harm.
Teen Received Prescription Within an Hour, Family Says
Nineteen-year-old Luke Tyler, a kinesiology major and aspiring physical therapist, signed up for the Hims platform in August 2022. According to the complaint filed Wednesday in King County Superior Court, he received a prescription for bupropion — an antidepressant tied to heightened suicidality in teens — within an hour of creating his account.
Tyler told the Hims provider that he had undiagnosed depression, past self-harm, and was searching for a low-cost way to cope without worrying his parents. Yet, the suit claims, no meaningful follow-up occurred.
Dosage Doubled Without Assessment
“No Questions, Just More Pills,” Parents Say
At the start of his freshman year, Tyler began taking the medication while pledging the Theta Chi fraternity. His parents say he faced intense hazing, compounding his emotional strain.
A month later, Tyler messaged the provider again, reporting he felt no improvement except increased irritability. Instead of evaluating him, the provider doubled his dosage to 300 mg and issued 90 pills with automatic refills — even though he still possessed most of his initial prescription.
The complaint emphasizes that studies link bupropion to increased suicidal behavior among teens aged 13 to 19, and that youth who self-harm using bupropion face higher rates of severe medical complications than those using other antidepressants.
